Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

The influence of comorbid personality disorder on the effects of behavioural activation vs. antidepressant medication for major depressive disorder: results from a randomized trial in Iran.

Moradveisi L, Huibers MJ, Renner F, Arasteh M, Arntz A.

Behav Res Ther. 2013 Aug;51(8):499-506. doi: 10.1016/j.brat.2013.05.006. Epub 2013 May 30.

PMID:
23792179
2.

Behavioural activation v. antidepressant medication for treating depression in Iran: randomised trial.

Moradveisi L, Huibers MJ, Renner F, Arasteh M, Arntz A.

Br J Psychiatry. 2013 Mar;202(3):204-11. doi: 10.1192/bjp.bp.112.113696. Epub 2013 Feb 7.

3.

The influence of patients' preference/attitude towards psychotherapy and antidepressant medication on the treatment of major depressive disorder.

Moradveisi L, Huibers M, Renner F, Arntz A.

J Behav Ther Exp Psychiatry. 2014 Mar;45(1):170-7. doi: 10.1016/j.jbtep.2013.10.003. Epub 2013 Oct 15.

PMID:
24172145
4.

Dysfunctional cognitions of depressive inpatients and their relationship with treatment outcome.

Köhler S, Unger T, Hoffmann S, Mackert A, Ross B, Fydrich T.

Compr Psychiatry. 2015 Apr;58:50-6. doi: 10.1016/j.comppsych.2014.12.020. Epub 2015 Jan 13.

PMID:
25639696
5.

The influence of patients' attributions of the immediate effects of treatment of depression on long-term effectiveness of behavioural activation and antidepressant medication.

Moradveisi L, Huibers MJ, Arntz A.

Behav Res Ther. 2015 Jun;69:83-92. doi: 10.1016/j.brat.2015.04.007. Epub 2015 Apr 14.

PMID:
25898343
6.

Depressive personality and treatment outcome in major depressive disorder.

Ryder AG, Quilty LC, Vachon DD, Bagby RM.

J Pers Disord. 2010 Jun;24(3):392-404. doi: 10.1521/pedi.2010.24.3.392.

PMID:
20545502
7.

Does personality disorder co-morbidity impact treatment outcome for patients with major depression? A multi-level analysis.

De Bolle M, De Fruyt F, Quilty LC, Rolland JP, Decuyper M, Bagby RM.

J Pers Disord. 2011 Feb;25(1):1-15. doi: 10.1521/pedi.2011.25.1.1.

PMID:
21309619
8.

Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.

Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RM, Keller MB.

J Clin Psychiatry. 2003 May;64(5):554-61.

PMID:
12755659
9.

The relationship of personality disorders to treatment outcome in depressed outpatients.

Mulder RT, Joyce PR, Luty SE.

J Clin Psychiatry. 2003 Mar;64(3):259-64.

PMID:
12716266
10.

Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.

Lynch TR, Cheavens JS, Cukrowicz KC, Thorp SR, Bronner L, Beyer J.

Int J Geriatr Psychiatry. 2007 Feb;22(2):131-43.

PMID:
17096462
11.

Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders.

Kool S, Dekker J, Duijsens IJ, de Jonghe F, Puite B.

Harv Rev Psychiatry. 2003 May-Jun;11(3):133-41.

PMID:
12893503
12.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
13.

Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.

Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, Manber R, Blalock JA, Keitner GI, Thase ME.

J Affect Disord. 2009 Oct;117(3):174-9. doi: 10.1016/j.jad.2009.01.010. Epub 2009 Feb 12.

PMID:
19217168
14.

Personality disorders and depression.

Fava M, Farabaugh AH, Sickinger AH, Wright E, Alpert JE, Sonawalla S, Nierenberg AA, Worthington JJ 3rd.

Psychol Med. 2002 Aug;32(6):1049-57.

PMID:
12214786
15.

Problem-solving ability and comorbid personality disorders in depressed outpatients.

Harley R, Petersen T, Scalia M, Papakostas GI, Farabaugh A, Fava M.

Depress Anxiety. 2006;23(8):496-501.

PMID:
16845662
16.

Clinical study results from a randomized controlled trial of cognitive behavioural guided self-help in patients with partially remitted depressive disorder.

Schlögelhofer M, Willinger U, Wiesegger G, Eder H, Priesch M, Itzlinger U, Bailer U, Schosser A, Leisch F, Aschauer H.

Psychol Psychother. 2014 Jun;87(2):178-90. doi: 10.1111/papt.12008. Epub 2013 May 17.

PMID:
23681925
17.

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruberto A, Tatarelli R, Nicoletti F, Girardi P, Shelton RC.

J Psychiatr Res. 2009 Jan;43(3):247-54. doi: 10.1016/j.jpsychires.2008.03.014. Epub 2008 Jun 3.

18.

Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

Barber JP, Barrett MS, Gallop R, Rynn MA, Rickels K.

J Clin Psychiatry. 2012 Jan;73(1):66-73. doi: 10.4088/JCP.11m06831. Epub 2011 Nov 29.

PMID:
22152401
19.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
20.

Supplemental Content

Support Center